Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Chemogenomics Laboratory, IMIM-Hospital del Mar and University Pompeu Fabra, Barcelona, Spain.
The link between cyclobenzaprine (Flexeril) administration and serotonin syndrome (SS) is subject to debate. Establishing such a connection is difficult because of the limited number of case reports available and the almost complete ignorance of its preclinical pharmacology. In this context, evidence is provided here that cyclobenzaprine blocks the serotonin and norepinephrine transporters and binds to another set of five serotonin receptors. SS should be considered when indicative signs occur in the context of cyclobenzaprine use.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on